Table 1 Anthropometric characteristics and functional status of the study groups
Control subjects (n = 7)COPD patients (n = 15)
Age (years)62 (6)62 (7)
BMI (kg/m2)27.9 (5.1)24.4 (6.2)
FFMI (kg/m2)22.3 (2.5)20.0 (3.5)
FEV1 (l)3.2 (0.5)1.4 (0.6)***
FEV1 (% pred)95 (15)41 (18)***
FVC (% pred)97 (12)68 (18)***
FEV1/FVC (%)78 (5)44 (12)***
RV (% pred)NA177 (48)
Tlco (% pred)NA50 (21)
Pao2 (kPa)12.6 (1.7)9.9 (1.3)*
Paco2 (kPa)4.9 (0.5)5.6 (0.8)
Q isometric (Nm)205 (31)153 (58)*
Q isokinetic (Nm)129 (30)92 (43)*
Q endurance (J)2200 (599)1480 (725)**
Vo2peak (% pred)100 (16)57 (30)*
WRpeak (% pred)100 (18)48 (25)*
  • Data are presented as mean (SD).

  • BMI, body mass index; COPD, chronic obstructive pulmonary disease; FEV1, forced expiratory volume in 1 s; FEV1/FVC, FEV1/FVC ratio expressed as actual percentage; FFMI, fat free mass index; FVC, forced vital capacity; J, Jules; NA, not available; Nm, Newton metres; Paco2, arterial carbon dioxide tension; Pao2, arterial oxygen tension; pred, predicted; Q, quadriceps force; RV, residual volume; Tlco, carbon monoxide transfer factor; Vo2peak, peak exercise oxygen uptake; WRpeak, peak work rate.

  • *p⩽0.05, **p = 0.06, ***p⩽0.001 between patients with COPD and control subjects.